Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Inventory (2024 - 2025)

ASP Isotopes has reported Inventory over the past 2 years, most recently at $1.1 million for Q4 2025.

  • On a quarterly basis, Inventory rose 1563.64% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 1563.64% increase, with the full-year FY2025 number at $1.1 million, up 1563.64% from a year prior.
  • Inventory reached $1.1 million in Q4 2025 per ASPI's latest filing, down from $1.4 million in the prior quarter.
  • The five-year high for Inventory was $1.4 million in Q3 2025, with the low at $66000.0 in Q4 2024.